Pfizer Inc. and Merck & Co. are both expected to show the effects of increased competition from generic drugs when the two pharmaceutical bellwethers roll out their third-quarter earnings reports next week.

These are the best ETFs over the last four weeks.

U.S. stock market futures dropped sharply Friday after the latest payrolls report came in much worse than expected, following a week of generally negative economic releases.

U.S. stock futures dip Friday ahead of the key monthly payrolls report as traders fret that a week of generally negative economic releases could continue.

Among the companies whose shares are expected to see active trade in Wednesday’s session are Boston Scientific, CIT, Darden Restaurants, Granite Construction, Jabil Circuit, J&J, Micron Technology, Nike, Omnova, Onyx Pharma, Sealy and TransDigm.

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts LLC.

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com.

– Franchise includes subcutaneous RELISTOR, only drug approved for opioid-induced constipation; marketed in 30 countries –

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal.